BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,121,000 | +20.9% | 10,000 | 0.0% | 0.04% | +27.3% |
| Q3 2020 | $927,000 | +18.8% | 10,000 | 0.0% | 0.03% | +6.5% |
| Q2 2020 | $780,000 | +33.3% | 10,000 | 0.0% | 0.03% | +19.2% |
| Q1 2020 | $585,000 | -27.0% | 10,000 | 0.0% | 0.03% | 0.0% |
| Q4 2019 | $801,000 | +9.0% | 10,000 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $735,000 | -80.6% | 10,000 | -78.9% | 0.03% | -81.8% |
| Q1 2019 | $3,786,000 | +48.5% | 47,300 | 0.0% | 0.14% | +27.7% |
| Q4 2018 | $2,550,000 | -28.2% | 47,300 | +4.0% | 0.11% | -21.7% |
| Q3 2018 | $3,552,000 | +5.6% | 45,500 | -14.2% | 0.14% | -7.7% |
| Q2 2018 | $3,364,000 | -4.1% | 53,000 | +38.6% | 0.16% | -10.9% |
| Q1 2018 | $3,508,000 | – | 38,250 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |